572 related articles for article (PubMed ID: 36881791)
1. Acute oesophageal safety and long-term follow-up of AI-guided high-power short-duration with 50 W for atrial fibrillation ablation.
Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Zhuravlev V; Chakarov I; Barth S; Waechter C; Behnes M; Halbfass P; Deneke T
Europace; 2023 Apr; 25(4):1379-1391. PubMed ID: 36881791
[TBL] [Abstract][Full Text] [Related]
2. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
[TBL] [Abstract][Full Text] [Related]
3. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.
Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Chakarov I; Barth S; Waechter C; Lüsebrink U; Behnes M; Akin I; Deneke T
J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1425-1434. PubMed ID: 35441414
[TBL] [Abstract][Full Text] [Related]
5. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial).
Chieng D; Segan L; Sugumar H; Al-Kaisey A; Hawson J; Moore BM; Nam MCY; Voskoboinik A; Prabhu S; Ling LH; Ng JF; Brown G; Lee G; Morton J; Debinski H; Kalman JM; Kistler PM
Europace; 2023 Feb; 25(2):417-424. PubMed ID: 36305561
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of atrial fibrillation-50 W or 90 W?
Mueller J; Nentwich K; Ene E; Berkovitz A; Sonne K; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Halbfass P; Deneke T
J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2504-2513. PubMed ID: 36124396
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of two 50 W high power short duration approaches-Temperature- versus ablation index-guided radiofrequency ablation for atrial fibrillation.
Guckel D; Bergau L; Braun M; El Hamriti M; Mörsdorf M; Fink T; Sciacca V; Khalaph M; Imnadze G; Sommer P; Sohns C
J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2517-2527. PubMed ID: 36104929
[TBL] [Abstract][Full Text] [Related]
8. Empirical superior vena cava isolation in patients undergoing repeat catheter ablation procedure after recurrence of atrial fibrillation.
Simu G; Deneke T; Ene E; Nentwich K; Berkovitz A; Sonne K; Halbfass P; Arvaniti E; Waechter C; Müller J
J Interv Card Electrophysiol; 2022 Nov; 65(2):551-558. PubMed ID: 35857220
[TBL] [Abstract][Full Text] [Related]
9. Reconnection patterns after CLOSE-guided 50 W high-power-short-duration circumferential pulmonary vein isolation and substrate modification-PV reconnection might no longer be an issue.
Francke A; Scharfe F; Schoen S; Wunderlich C; Christoph M
J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1136-1145. PubMed ID: 35118734
[TBL] [Abstract][Full Text] [Related]
10. High-power, short-duration atrial fibrillation ablations using contact force sensing catheters: Outcomes and predictors of success including posterior wall isolation.
Winkle RA; Mead RH; Engel G; Kong MH; Salcedo J; Brodt CR; Patrawala RA
Heart Rhythm; 2020 Aug; 17(8):1223-1231. PubMed ID: 32272229
[TBL] [Abstract][Full Text] [Related]
11. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Kottmaier M; Popa M; Bourier F; Reents T; Cifuentes J; Semmler V; Telishevska M; Otgonbayar U; Koch-Büttner K; Lennerz C; Bartkowiak M; Kornmayer M; Rousseva E; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I
Europace; 2020 Mar; 22(3):388-393. PubMed ID: 31872249
[TBL] [Abstract][Full Text] [Related]
12. High-power, short-duration atrial fibrillation ablation compared with a conventional approach: Outcomes and reconnection patterns.
Hansom SP; Alqarawi W; Birnie DH; Golian M; Nery PB; Redpath CJ; Klein A; Green MS; Davis DR; Sheppard-Perkins E; Ramirez FD; Nair GM; Sadek MM
J Cardiovasc Electrophysiol; 2021 May; 32(5):1219-1228. PubMed ID: 33751694
[TBL] [Abstract][Full Text] [Related]
13. High-power short-duration versus low-power long-duration ablation guided by the ablation index.
Sousa PA; Puga L; Barra S; Adão L; Primo J; Khoueiry Z; Lebreiro A; Fonseca P; Pereira M; Lagrange P; d'Avila A; Oliveiros B; Elvas L; Gonçalves L
Int J Cardiol; 2023 Jan; 370():209-214. PubMed ID: 36228764
[TBL] [Abstract][Full Text] [Related]
14. Esophageal safety in CLOSE-guided 50 W high-power-short-duration pulmonary vein isolation: The PREHEAT-PVI-registry.
Francke A; Naumann G; Weidauer MC; Scharfe F; Schoen S; Wunderlich C; Christoph M
J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2276-2284. PubMed ID: 35979645
[TBL] [Abstract][Full Text] [Related]
15. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
[TBL] [Abstract][Full Text] [Related]
16. Incidence of ablation-induced esophageal lesions and gastroparesis in patients undergoing ablation index guided high power short duration atrial fibrillation ablation.
List S; Meinhardt C; Mueller J; Deneke T; Barth S; Waechter C; Luesebrink U; Elsaesser A; Arlt A; Halbfass P
J Cardiovasc Electrophysiol; 2023 Jan; 34(1):82-89. PubMed ID: 36321661
[TBL] [Abstract][Full Text] [Related]
17. High-power application is associated with shorter procedure time and higher rate of first-pass pulmonary vein isolation in ablation index-guided atrial fibrillation ablation.
Okamatsu H; Koyama J; Sakai Y; Negishi K; Hayashi K; Tsurugi T; Tanaka Y; Nakao K; Sakamoto T; Okumura K
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2751-2758. PubMed ID: 31600006
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of lesion size index-guided high-power radiofrequency catheter ablation for pulmonary vein isolation in patients with atrial fibrillation: 2-year follow-up.
Cai C; Wang J; Niu HX; Chu JM; Hua W; Zhang S; Yao Y
J Cardiovasc Electrophysiol; 2023 Mar; 34(3):546-555. PubMed ID: 36640429
[TBL] [Abstract][Full Text] [Related]
19. Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high-power short-duration pulmonary vein isolation and substrate modification using the CLOSE protocol.
Francke A; Taha NS; Scharfe F; Schoen S; Wunderlich C; Christoph M
J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2408-2417. PubMed ID: 34252990
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation ablation workflow optimization facilitated by high-power short-duration ablation and high-resolution mapping.
Fink T; Sciacca V; Nischik F; Bergau L; Guckel D; El Hamriti M; Khalaph M; Braun M; Winnik S; Didenko M; Imnadze G; Sommer P; Sohns C
Europace; 2024 Mar; 26(3):. PubMed ID: 38516791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
